The future of Parkinson's disease treatments

Lars Wojtecki, MD, PhD, Institute of Clinical Neuroscience and Medical Psychology, University Düsseldorf, Düsseldorf, Germany, shares his perspectives on the future of treatment landscape of Parkinson’s disease. Prof. Wojtecki believes that the upcoming treatments, some already in development, will target beyond the dopaminergic pathway. Regarding deep brain stimulation, past learnings will improve its use in the future. However, the biggest challenge going forward is interfering with the cause of Parkinson’s disease. Therefore, it is essential to develop treatments that are not only symptomatic but target the underlying cause. This interview was conducted during the virtual 2021 World Congress on Controversies in Neurology (CONy).